Drug recall · January 24, 2018
Mefenamic Acid Capsules recall
Why: Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OH 45040, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ 07981, NDC 66993-070-30
- Lots / codes
Lot#: 7H66200103G, Exp 12/19
- Quantity
- 968 bottles
- Company
- Shionogi Inc., Alpharetta, GA
- Distribution
- U.S.A. Nationwide
- Initiated
- May 24, 2017 · Voluntary: Firm initiated
- Classified
- January 12, 2018
- Reported
- January 24, 2018
- Ended
- February 28, 2018
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.